ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1634

Association of Ultra-processed Food Intake with Risk of Systemic Lupus Erythematosus in Women

Sinara Laurini Rossato1, Chun-Han Lo2, Medha Barbhaiya3, Jeffrey Sparks4, Neha Khandpur5, Susan Malspeis6, Kazuki Yoshida6, Walter C. Willett7 and Karen Costenbader6, 1Universidade Federal de Uberlândia, Uberlândia, Brazil, 2Kirk Kerkorian School of Medicine at UNLV, Las Vegas, 3Hospital for Special Surgery, New York, NY, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Harvard TH Chan School of Public Health, Boston, MA, 6Brigham and Women's Hospital, Boston, MA, 7Harvard TH Chan School of Public Health, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2022

Keywords: diet, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Epidemiology and Public Health I: Risk Factors and Outcomes

Session Type: Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Antioxidants and vitamins present in unprocessed foods may protect against development of systemic lupus erythematosus (SLE) whereas ultra-processed foods (UPFs) remove these nutrients, adding stabilizers and emulsifiers, and may thus increase SLE risk. We assessed the association of UPF intake and SLE incidence in two cohorts of women with more than 20 years of follow-up.

Methods: We included 78,911 women in the Nurses’ Health Study (NHS) followed from 1984 to 2010 and 91,079 women in NHS II followed 1991 to 2015. Diet was assessed using a validated semi-quantitative food frequency questionnaire and the NOVA food classification system was used to categorize food intake and quantity into UPF. UPFs are ready-to-eat industrial formulations that normally contain added flavors, and cosmetic additives (e.g. sugar-sweetened beverages, muffins, bagels, candies, salad dressing, and processed meat). Participants who reported new doctor-diagnosed connective tissue disease (CTD) including SLE on one of the two-year medical assessment follow-ups completed the Connective Tissue Disease Questionnaire and cases were confirmed on medical record review. Time-varying Cox regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) for incident SLE. UPF intake, assessed as number of servings/day in tertiles, was the exposure. Models were adjusted for age, race, cohort, total energy intake, household income, smoking, body mass index (BMI in kg/m2), physical activity, age at menarche, oral contraceptive, multivitamin, and menopausal hormone status. We investigated effect modification by BMI in stratified models.

Results: Mean age at baseline was ~50 years old in NHS and ~36 years old in NHSII. (Table 1) Participants were predominantly White (90-95%). In the pooled analysis of NHS and NHSII, 200 cases of SLE were identified over 26 years follow-up in NHS and 24 years in NHSII. After multivariable adjustment, risk was higher in the 3rd than 1st UPF intake tertile (HR 1.45, 95%CI 1.03 – 2.05, p 0.03). For positive dsDNA SLE risk, the risk was also higher 1st vs. 3rd tertile (HR 1.62, 95%CI 0.98 – 2.69, p 0.05) (Table 2). Participants with BMI ≥ 25 kg/m² had higher SLE risk in the 3rd vs. 1st tertile of UPF intake servings/day (HR 1.66, 95% CI 1.03 -2.67, p 0.02) than among those with lower BMI (Figure 1).

Conclusion: Women in the highest tertile of cumulatively updated dietary UPF intake/day were at almost 50% greater risk of developing SLE compared to women in the lowest tertile of UPF daily intake. In addition, elevated SLE risk associated with high UPF intake was more significant among participants with overweight and obesity than among those with normal BMI. These novel findings deserve further study.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Rossato, None; C. Lo, None; M. Barbhaiya, None; J. Sparks, Bristol Myers Squibb, AbbVie/Abbott, Amgen, Boehringer Ingelheim, Gilead, Inova Diagnostics, Janssen, Optum, Pfizer; N. Khandpur, None; S. Malspeis, None; K. Yoshida, None; W. Willett, None; K. Costenbader, Eli Lilly, Janssen, Amgen, AstraZeneca Pharmaceuticals LP, GlaxoSmithKline(GSK), Gilead, Exagen, Neutrolis, Cel-Sci, Alkermes.

To cite this abstract in AMA style:

Rossato S, Lo C, Barbhaiya M, Sparks J, Khandpur N, Malspeis S, Yoshida K, Willett W, Costenbader K. Association of Ultra-processed Food Intake with Risk of Systemic Lupus Erythematosus in Women [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/association-of-ultra-processed-food-intake-with-risk-of-systemic-lupus-erythematosus-in-women/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-ultra-processed-food-intake-with-risk-of-systemic-lupus-erythematosus-in-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology